Overview

Study of Fluoxetine in Autism

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effect of fluoxetine orally dissolving tablets (ODT) on the repetitive behaviors core domain in children and adolescents with Autistic Disorder. The study will also investigate the effect of fluoxetine on the improvement of symptoms and the effects on daily living of the patient's family.
Phase:
Phase 3
Details
Lead Sponsor:
Neuropharm
Collaborator:
Autism Speaks
Treatments:
Fluoxetine
Serotonin Uptake Inhibitors